Variation in Nicotine Metabolization According to Biological Factors and Type of Nicotine Consumer

This study aims to describe the nicotine metabolite ratio among tobacco smokers and electronic cigarette (e-cigarette) users and nonusers. We analyzed pooled data from a longitudinal and a cross-sectional study of the adult population from the city of Barcelona. The final sample included information on 166 smokers, 164 e-cigarettes users with nicotine, 41 e-cigarette users without nicotine, 95 dual users (users of both products), and 508 nonusers. We used log-linear models to control for the potential confounding effect of the daily number of cigarettes smoked. Salivary nicotine metabolic rate assessment included the rate of nicotine metabolism (cotinine/nicotine) and the nicotine metabolite ratio (trans-3′-hydroxycotinine/cotinine). Exclusive users of e-cigarette without nicotine have the lowest rate of nicotine metabolism (Geometric mean: 0.08, p-values < 0.001) while cigarette smokers have the highest (Geometric mean: 2.08, p-values < 0.001). Nonusers have lower nicotine metabolic rate than cigarette smokers (Geometric means: 0.23 vs. 0.18, p-value < 0.05). Younger individuals (18–44 years) have a higher rate of nicotine metabolism than older individuals (45–64 years and 65–89) (Geometric means: 0.53 vs. 0.42 and 0.31, respectively, p-values < 0.01) and individuals with lower body mass index (21–25 kg/m2) have a higher rate of nicotine metabolism than the rest (26–30 kg/m2 and 31–60 kg/m2) (Geometric means: 0.52 vs. 0.35 and 0.36, respectively-values < 0.01). Nicotine metabolic rates are useful biomarkers when reporting smoking status and biological differences between individuals.

[1]  S. McKee,et al.  Associations Between Nicotine Metabolite Ratio and Gender With Transitions in Cigarette Smoking Status and E-Cigarette Use: Findings Across Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[2]  C. Lerman,et al.  The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions , 2020, Cancer Prevention Research.

[3]  R. Jain Nicotine metabolite ratios in serum and urine among US adults: variations across smoking status, gender and race/ethnicity , 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  Sungkyu Lee,et al.  Daily Cigarette Consumption and Urine Cotinine Level between Dual Users of Electronic and Conventional Cigarettes, and Cigarette-Only Users , 2019, Journal of psychoactive drugs.

[5]  S. Gregorich,et al.  Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors. , 2019, Journal of the National Medical Association.

[6]  xiao jin,et al.  The relationship between smoking and stroke , 2019, Medicine.

[7]  R. Jackler,et al.  Nicotine arms race: JUUL and the high-nicotine product market , 2019, Tobacco Control.

[8]  X. Correig,et al.  Biomarkers of Exposure to Secondhand and Thirdhand Tobacco Smoke: Recent Advances and Future Perspectives , 2018, International journal of environmental research and public health.

[9]  P. Spicer,et al.  E-cigarettes and Tobacco Exposure Biomarkers among American Indian Smokers. , 2018, American Journal of Health Behavior.

[10]  B. Vaidya,et al.  Nicotine and electronic cigarette (E‐Cig) exposure decreases brain glucose utilization in ischemic stroke , 2018, Journal of neurochemistry.

[11]  J. Nonnemaker,et al.  Examining Daily Electronic Cigarette Puff Topography Among Established and Nonestablished Cigarette Smokers in their Natural Environment , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  J. Muscat,et al.  Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study. , 2018, Drug and alcohol dependence.

[13]  M. Munafo,et al.  The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study , 2018, bioRxiv.

[14]  R. Jain Revised and extended serum cotinine cut-offs to classify smokers and non-smokers , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[15]  S. Krishnan-Sarin,et al.  E-cigarettes: Impact of E-liquid Components and Device Characteristics on Nicotine Exposure , 2017, Current neuropharmacology.

[16]  E. Fernández,et al.  Impact of the Spanish smoking laws on tobacco consumption and secondhand smoke exposure: A longitudinal population study. , 2017, Addictive behaviors.

[17]  E. Fernández,et al.  Assessment of salivary cotinine concentration among general non-smokers population: Before and after Spanish smoking legislations. , 2017, Cancer epidemiology.

[18]  E. Fernández,et al.  Uso de paneles de consumidores en estudios observacionales de salud pública , 2017 .

[19]  E. Fernández,et al.  Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study. , 2016, Environmental research.

[20]  E. Fernández,et al.  Impact of the Spanish smoking legislations in the adoption of smoke-free rules at home: a longitudinal study in Barcelona (Spain) , 2016, Tobacco Control.

[21]  Kunal Jha,et al.  Diagnostic Methods for Detection of Cotinine Level in Tobacco Users: A Review. , 2016, Journal of clinical and diagnostic research : JCDR.

[22]  C. Lerman,et al.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio , 2016, Journal of Neuroimmune Pharmacology.

[23]  J. Kaprio,et al.  Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[24]  L. Hawk,et al.  Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[25]  S. Grando,et al.  Connections of nicotine to cancer , 2014, Nature Reviews Cancer.

[26]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .

[27]  T. Arafat,et al.  Effect of mint drink on metabolism of nicotine as measured by nicotine to cotinine ratio in urine of Jordanian smoking volunteers. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[28]  S. Heishman,et al.  Oral Fluid Nicotine Markers to Assess Smoking Status and Recency of Use , 2011, Therapeutic drug monitoring.

[29]  H. McRobbie,et al.  Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence , 2011, Psychopharmacology.

[30]  E. Fernández,et al.  Punto de corte óptimo de la concentración de cotinina en saliva para discriminar entre fumadores y no fumadores en la población adulta de Barcelona , 2009 .

[31]  E. Fernández,et al.  Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study , 2009, BMC public health.

[32]  E. Fernández,et al.  [Optimal cut-point of salivary cotinine concentration to discriminate smoking status in the adult population in Barcelona]. , 2009, Gaceta Sanitaria.

[33]  D. Hatsukami,et al.  Stability of the Nicotine Metabolite Ratio in ad Libitum and Reducing Smokers , 2008, Cancer Epidemiology Biomarkers & Prevention.

[34]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[35]  N. Benowitz,et al.  Determinants of the rate of nicotine metabolism and effects on smoking behavior , 2006, Clinical pharmacology and therapeutics.

[36]  R. Tyndale,et al.  CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum Smoking , 2006, Cancer Epidemiology Biomarkers & Prevention.

[37]  Rod A Lea,et al.  Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate. , 2006, Journal of analytical toxicology.

[38]  Christina N. Lessov-Schlaggar,et al.  Female sex and oral contraceptive use accelerate nicotine metabolism , 2006, Clinical pharmacology and therapeutics.

[39]  N. Benowitz,et al.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity , 2004, Clinical pharmacology and therapeutics.

[40]  S. Ulijaszek Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Pp. 252. (World Health Organization, Geneva, 2000.) SFr 56.00, ISBN 92-4-120894-5, paperback. , 2003 .

[41]  A. Hansson,et al.  Pharmacokinetics of nicotine in healthy elderly people , 2001, Clinical pharmacology and therapeutics.